D Valteau-Couanet
Overview
Explore the profile of D Valteau-Couanet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
691
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Phulpin-Weibel A, Gaspar N, Emirian A, Chachaty E, Valteau-Couanet D, Gachot B
J Med Microbiol
. 2013 Feb;
62(Pt 5):789-791.
PMID: 23378563
Bacteraemia and endocarditis are the most frequently reported clinical infections due to Abiotrophia defectiva species. This species has been rarely implicated in infections in neutropenic patients. We report a rare...
12.
Veal G, Nguyen L, Paci A, Riggi M, Amiel M, Valteau-Couanet D, et al.
Eur J Cancer
. 2012 Jun;
48(16):3063-72.
PMID: 22742881
Introduction: Busulfan is widely used in a neuroblastoma setting, with several studies reporting marked inter-patient variability in busulfan pharmacokinetics and pharmacodynamics. The current study reports on the pharmacokinetics of oral...
13.
Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
Gattolliat C, Thomas L, Ciafre S, Meurice G, Le Teuff G, Job B, et al.
Br J Cancer
. 2011 Oct;
105(9):1352-61.
PMID: 21970883
Background: Combination of age at diagnosis, stage and MYCN amplification stratifies neuroblastoma into low-risk and high-risk. We aimed to establish whether a microRNA (miRNA) signature could be associated with prognosis...
14.
Fresneau B, Oberlin O, Brugieres L, Valteau-Couanet D, Patte C
Arch Pediatr
. 2010 Mar;
17(5):495-501.
PMID: 20338733
Primary heart tumors are uncommon in children. The majority of them are benign, with only 10% malignant. Among malignant cardiac tumors, sarcoma (rhabdomyosarcoma, angiosarcoma, synovial sarcoma) and lymphoma (Burkitt's lymphoma,...
15.
Milcent K, Franchi-Abella S, Larrar S, Guitton C, Valteau-Couanet D, Kone-Paut I, et al.
Arch Pediatr
. 2008 Nov;
15(12):1756-9.
PMID: 18976891
Retroperitoneal fibrosis (RF) is a rare disease in children. We report the case of a 15-year-old boy who presented with a 2-month history of dorsal pain and a 2-week history...
16.
Valteau-Couanet D, Dubrel M, Dufour C, Couanet D, Hartmann O, Patte C
Arch Pediatr
. 2008 Jun;
15(5):781-2.
PMID: 18582748
No abstract available.
17.
Schleiermacher G, Michon J, Huon I, dEnghien C, Klijanienko J, Brisse H, et al.
Br J Cancer
. 2007 Jun;
97(2):238-46.
PMID: 17579628
Whereas neuroblastoma (NB) with MYCN amplification presents a poor prognosis, no single marker allows to reliably predict outcome in tumours without MYCN amplification. We report here an extensive analysis of...
18.
Vassal G, Michel G, Esperou H, Gentet J, Valteau-Couanet D, Doz F, et al.
Cancer Chemother Pharmacol
. 2007 Mar;
61(1):113-23.
PMID: 17393167
Introduction: Oral busulfan clearance is age-dependent and children experience a wide variability in plasma exposure. BSA- or age-based dosing is used with therapeutic drug monitoring (TDM) to reduce this variability....
19.
Bouligand J, Le Maitre A, Valteau-Couanet D, Grill J, Drouard-Troalen L, Paci A, et al.
Clin Pharmacol Ther
. 2007 Mar;
82(4):402-9.
PMID: 17392724
Hepatic veno-occlusive disease (HVOD) is a frequent complication during hematopoietic stem-cell transplantation (HSCT). A strong relationship has been demonstrated between busulfan exposure and HVOD for busulfan-cyclophosphamide and allogeneic HSCT in...
20.
Valteau-Couanet D, Fillipini B, Benhamou E, Grill J, Kalifa C, Couanet D, et al.
Bone Marrow Transplant
. 2005 Sep;
36(11):939-45.
PMID: 16184181
We previously demonstrated that Busulfan-Thiotepa (Bu-Thio) and ASCT effectively treated patients with locally relapsed medulloblastoma after surgery and conventional chemotherapy. We thus evaluated the administration of Bu-Thio in patients relapsing...